Merck filed for approval of gefapixant in March 2021 on the strength of a pair of phase 3 trials – COUGH-1 and COUGH-2 – which found that the drug reduced 24-hour cough frequency by 18% and 15 ...

Bayer says its drug candidate for chronic cough – eliapixant – has hit the mark in a phase 2b trial, putting it in hot pursuit of Merck & Co's gefapixant, which was filed for approval in March.

Increase in ER Visits, Hospital Admissions is Driven by Flu; IDPH Urges Public To Quickly Seek Testing and Treatment if they Experience Flu-like Symptoms The Illinois Department of Public Health (IDPH ...

The German drugmaker confirmed acquisition talks, but cautioned a deal may not materialize. Elsewhere, Biohaven got priority ...

Behavioral cough suppression therapy may be effective in patients with refractory and unexplained chronic cough (RCC and UCC).

Recent findings suggest that post-COVID chronic cough may be driven by neurological factors, not just respiratory issues.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

From seasonal irritations to serious health indicators, medical experts explain the hidden meanings behind different types of ...

Early signs of whooping cough in adults look very much like a common cold, Dr. Loafman says. For the first week or so of ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Keep reading to learn more about the possible causes of a dry cough and ways to find relief. Gastroesophageal reflux disease (GERD) is a type of chronic acid reflux. It happens when stomach acid ...

While unfortunately, the same state's Department of Health reports their flu rates have reportedly increased 90% week-over-week.